Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (FH2 Pharma LLC)

View source ↗

Summary

FDA approved FH2 Pharma LLC's supplemental application for OXYCODONE AND ACETAMINOPHEN tablets, enabling its marketing as a generic product under ANDA 040608.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)